<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aortic valve replacement (AVR) using allografts is an established method of treating <z:e sem="disease" ids="C1260873" disease_type="Disease or Syndrome" abbrv="">aortic valve disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It is uncertain, however, whether the increased technical demands of allograft AVR can be justified in emergency operations </plain></SENT>
<SENT sid="2" pm="."><plain>This study reports 15 patients treated between 1987 and 1990 for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001794'>bacterial</z:mp> or fungal <z:hpo ids='HP_0100584'>endocarditis</z:hpo> involving the aortic valve </plain></SENT>
<SENT sid="3" pm="."><plain>Patients underwent emergency AVR because of severe congestive failure, overwhelming <z:hpo ids='HP_0100806'>sepsis</z:hpo> or <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral emboli</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Eight patients received prosthetic valves (group I: 4 mechanical, 4 porcine) and 7 received human allografts (group II: 5 aortic and 2 pulmonary) </plain></SENT>
<SENT sid="5" pm="."><plain>The groups were comparable in age (group I, 55 years; group II, 51 years), <z:e sem="disease" ids="C0086181" disease_type="Mental or Behavioral Dysfunction" abbrv="ivda|IVDA">intravenous drug abuse</z:e> (group I, 1; group II, 3), and previous AVR (group I, 3; group II, 2) </plain></SENT>
<SENT sid="6" pm="."><plain>One group I and 4 group II patients had septal abscesses </plain></SENT>
<SENT sid="7" pm="."><plain>Additional procedures in group I included mitral valve replacement (2), tricuspid valve replacement (1) and aortic root replacement (1) </plain></SENT>
<SENT sid="8" pm="."><plain>Additional procedures in group II were mitral valve repair (1), root replacement (1), <z:hpo ids='HP_0001631'>atrial septal defect</z:hpo> closure (1) and aortocoronary bypass (1) </plain></SENT>
<SENT sid="9" pm="."><plain>Mean bypass times (group I, 189 minutes; group II, 204 minutes) and cross-clamp times (group I; 108 minutes; group II, 121 minutes) were similar </plain></SENT>
<SENT sid="10" pm="."><plain>Operative <z:hpo ids='HP_0011420'>deaths</z:hpo> occurred in 4 of 8 group I and 1 of 7 group II patients </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> surviving patients have been successfully followed (group I, 28 months; group II, 18 months) </plain></SENT>
<SENT sid="12" pm="."><plain>No group I patient has required reoperation </plain></SENT>
<SENT sid="13" pm="."><plain>One group II patients required reoperation for recurrent <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> affecting the allograft, and another group II patient died 10 months postoperatively from noncardiac causes.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>